))
51: Jorge Santos da Silva: Visão de CEO de startup biotecnológica
Manage episode 344490124 series 3381015
Innehåll tillhandahållet av André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Jorge Santos da Silva, Fundador e CEO da MoonLake Immunotherapeutics sobre biotech, investimentos e inovação e, sobre como Portugal é visto por alguém com uma grande experiência internacional.
Jorge Santos da Silva, is a co-Founder of MoonLake and has served as the Chief Executive Officer of MoonLake since July 2021, being also a Director of the Board. Prior to MoonLake, he was at McKinsey & Company, Inc. from September 2007 to June 2021, where he was a Senior Partner and led the Pharmaceutical & Medical Products Practice, the Biotech group and the Biosimilars group and advised international biopharmaceutical and biotechnology companies on corporate and business-unit strategy, commercial operating models, R&D, organizational design, M&A and joint ventures. Dr. Santos da Silva was a Postdoctoral Fellow at Cold Spring Harbor Laboratory, NY (USA) and holds a Ph.D. in Neuronal Cell Biology from the University of Turin (Italy) and a MSc in Molecular Biology from the University of Glasgow — Institute of Biological and Life Sciences (United Kingdom) and the European Molecular Biology Laboratory, Heidelberg (Germany). He is also a professor and Board Advisor at the School of Medicine at the Minho University in Portugal.
Outras referências feitas no episódio:
Contactos:
86 episoder
Dela
